Intermolecular Grows IP Portfolio to Over 700 U.S. Patents and Patent Applications
Intermolecular, Inc. (Nasdaq: IMI) accelerating research and development (R&D) for semiconductor and clean-energy industries—today announced that its intellectual property (IP) portfolio has increased to 730 U.S. patents and patent applications. The company now owns or has exclusive rights to this portfolio which covers both its HPC innovation platform and the inventions resulting from deploying the platform for the benefit of its customers. The company filed 207 US patent applications in 2011, spanning innovations in semiconductor technology including advanced logic, DRAM, and Non-volatile Memory (NVM), as well as in clean-energy fields such as photovoltaics (PV), light-emitting diodes (LED), and energy-efficient glass.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.